Charles River keeps adding on to its CDMO arm, snatching up viral vector player
18 May 2021 //
ENDPTS
Charles River to Acquire Vigene Biosciences for up to $350 million
17 May 2021 //
PHARMTECH
Altimmune and CDMO Vigene Enter COVID-19 Vax Pact
03 Aug 2020 //
CONTRACTPHARM